Home > Insider Trading > Filing (0001127602-14-027606)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
884731	Ariad Pharmaceuticals Inc	ARIA	Biological Products, (No Disgnostic Substances) (2836)	223106987

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
932052	D M J Harvey Berger	C/O Ariad Pharmaceuticals, Inc. 26 Landsdowne Street Cambridge MA 02139	Chairman & Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-09-02	12,500	$6.22	1,726,786	No	4	P	Indirect	Ocean Capital Partners, Llc
Common Stock	Acquisiton	2014-09-03	12,500	$6.31	1,739,286	No	4	P	Indirect	Ocean Capital Partners, Llc
Common Stock	Acquisiton	2014-09-09	150,000	$5.23	1,294,277	No	4	M	Direct
Common Stock	Disposition	2014-09-09	124,613	$5.75	1,163,564	No	4	F	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	Ocean Capital Partners, Llc
No	4	P	Indirect	Ocean Capital Partners, Llc
No	4	M	Direct
No	4	F	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (Right to Buy)	Disposition	2014-09-09	150,000	$0.00	150,000	$5.23

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2007-09-09	2014-09-09	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	246,054	Indirect	Daughter
Common Stock	248,745	Indirect	Daughter
Common Stock	245,251	Indirect	Wife

Footnotes

Shares were aquired pursuant to a 10b5-1 plan.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.14 to $6.34, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Security and Exchange Commission, upon request, full information regarding the shares sold at each separate price within the range set forth in this footnote.
The reporting person is a managing member of this LLC.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.26 to $6.32, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Security and Exchange Commission, upon request, full information regarding the shares sold at each separate price within the range set forth in this footnote.
Shares were acquired upon the exercise of outstanding stock options at $5.23 per share.
Represents shares withheld to pay for the exercise cost related to the exercise of outstanding options and to satisfy withholding tax requirements.